Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma. [electronic resource]
Producer: 20100301Description: 458-61 p. digitalISSN:- 1879-0887
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Capecitabine
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Deoxycytidine -- administration & dosage
- Dose Fractionation, Radiation
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Humans
- Lymphatic Irradiation
- Lymphatic Metastasis
- Male
- Middle Aged
- Radiation Injuries
- Radiotherapy Dosage
- Radiotherapy, Intensity-Modulated
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.